Immunosuppressive reprogramming of neutrophils by lung mesenchymal cells promotes breast cancer metastasis
Science Immunology · 03.02.2023 · 8 (80)
DOI: 10.1126/sciimmunol.add5204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 03.02.2023. Verfasst von Zheng Gong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jackson Laboratory, Bar Harbor, ME 04609, USA. Hauptthemen laut MEDLINE: Neutrophils, Lung Neoplasms. Die Arbeit wurde bisher 135-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Neutrophils, the most abundant innate immune cells, function as crucial regulators of the adaptive immune system in diverse pathological conditions, including metastatic cancer. However, it remains largely unknown whether their immunomodulatory functions are intrinsic or acquired within the pathological tissue environment. Here, using mouse models of metastatic breast cancer in the lungs, we show that, although neutrophils isolated from bone marrow (BM) or blood are minimally immunosuppressive, lung-infiltrating neutrophils are robustly suppressive of both T cells and natural killer (NK) cells. We found that this tissue-specific immunosuppressive capacity of neutrophils exists in the steady state and is reinforced by tumor-associated inflammation. Acquisition of potent immunosuppression activity by lung-infiltrating neutrophils was endowed by the lung-resident stroma, specifically CD140a + mesenchymal cells (MCs) and largely via prostaglandin-endoperoxide synthase 2 (PTGS2), the rate-limiting enzyme for prostaglandin E 2 (PGE 2 ) biosynthesis. MC-specific deletion of Ptgs2 or pharmacological inhibition of PGE 2 receptors reversed lung neutrophil–mediated immunosuppression and mitigated lung metastasis of breast cancer in vivo. These lung stroma–targeting strategies substantially improved the therapeutic efficacy of adoptive T cell–based immunotherapy in treating metastatic disease in mice. Collectively, our results reveal that the immunoregulatory effects of neutrophils are induced by tissue-resident stroma and that targeting tissue-specific stromal factors represents an effective approach to boost tissue-resident immunity against metastatic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jackson Laboratory, Bar Harbor, ME 04609, USA.
- Tufts University School of Medicine, Boston, MA 02111, USA.
- Graduate School of Biomedical Sciences and Engineering, University of Maine, Orono, ME 04469, USA.
ORCID-Profile: Zheng Gong, Qing Li, Jiayuan Shi, Peishan Li, Leonard D Shultz, Guangwen Ren
Förderung
- NCI NIH HHS
- NIH HHS
Zitieren
APA
Gong, Z., Li, Q., Shi, J., Li, P., Hua, L., Shultz, L. D., & Ren, G. (2023). Immunosuppressive reprogramming of neutrophils by lung mesenchymal cells promotes breast cancer metastasis. Science Immunology, 8(80). https://doi.org/10.1126/sciimmunol.add5204
Vancouver
Gong Z, Li Q, Shi J, Li P, Hua L, Shultz LD, et al. Immunosuppressive reprogramming of neutrophils by lung mesenchymal cells promotes breast cancer metastasis. Science Immunology. 2023;8(80). doi:10.1126/sciimmunol.add5204
BibTeX
@article{Gong2023,
author = {Gong, Zheng and Li, Qing and Shi, Jiayuan and Li, Peishan and Hua, Li and Shultz, Leonard D and Ren, Guangwen},
title = {Immunosuppressive reprogramming of neutrophils by lung mesenchymal cells promotes breast cancer metastasis},
journal = {Science Immunology},
year = {2023},
volume = {8},
number = {80},
doi = {10.1126/sciimmunol.add5204}
}
EUVIMED